LUPIN vs MAXHEALTH vs AUROPHARMA vs GLENMARK: which stock is better?
Aurobindo Pharma Limited (AUROPHARMA) has the highest StockLens rating in this group at 8.1/10 (Excellent).
| Metric | LUPIN | MAXHEALTH | AUROPHARMA | GLENMARK |
|---|---|---|---|---|
| Overall rating | 6.0/10 (Average) | 4.6/10 (Average) | 8.1/10 (Excellent) | 4.6/10 (Average) |
| Long-term view | Good for long-term | Neutral (watchlist) | Strong long-term candidate | Neutral (watchlist) |
| Trade bias | Strong short | No clear edge | Strong long | Strong long |
| Share price | ₹1,950.00 | ₹1,030.90 | ₹1,794.10 | ₹2,615.80 |
| Market cap | ₹89,172 Cr | ₹1,00,340 Cr | ₹1,03,229 Cr | ₹73,824 Cr |
| P/E | 17.2 | 73.0 | 26.0 | 50.9 |
| Return on equity | 23.9% | 12.8% | 10.7% | 14.0% |
| Debt / equity | 0.26 | 0.33 | 0.22 | 0.13 |
| Revenue growth (YoY) | +11.1% | +20.3% | +23.9% | -29.8% |
| 1-year return | -2.0% | -6.1% | +59.6% | +42.9% |
Educational information, not investment advice. Data from Yahoo Finance and NSE Indices; prices may be delayed.